Avastin use for wet AMD and DMO

Ben Adams made this Freedom of Information request to Oxfordshire Primary Care Trust (PCT)

This request has been closed to new correspondence. Contact us if you think it should be reopened.

Oxfordshire Primary Care Trust (PCT) did not have the information requested.

Dear Oxfordshire Primary Care Trust (PCT),

I would like to know how many clinicians have been using the drug Avastin (bevacizumab) to treat patients with the eye conditions: wet age related macular degeneration and diabetic macular oedema between the 1st of January 2011 to the 1st of August 2012.

I would like the lists to separate - one for wet AMD, the other for DMO.

Yours faithfully,

Ben Adams

Jackson Kirsty (5QE) Oxfordshire PCT, Oxfordshire Primary Care Trust (PCT)

1 Attachment

Dear Mr Adam's,

Please find attached our acknowledgement letter for your Freedom of Information request.

With kind regards

Freedom of Information Team
NHS Buckinghamshire and Oxfordshire Cluster

01865 334 650

FOI (5QE) Oxfordshire PCT, Oxfordshire Primary Care Trust (PCT)

Good Afternoon

In reference to your FOI request below, the PCT does not hold this information. Please redirect your query to:

http://www.ouh.nhs.uk/about/foi/default.... - OUH FOI Website
[email address] – Email address

Many Thanks

Rachael Demain | Freedom Of Information Officer | NHS Buckinghamshire & Oxfordshire Cluster, Jubilee House, 5510 John Smith Drive, Oxford Business Park, Cowley, Oxford, OX4 2LH
|tel: 01865 334650 | email: [email address]| web: www.oxfordshirepct.nhs.uk

Follow us on Facebook ● Follow us on Twitter ● Come and Talk Health

For Freedom Of Information requests please email [NHS Oxfordshire request email]
Pager number: 07659 129167 This is the number to page a member of the communications team between 5pm – 9am, Monday to Friday and 24 HOURS at weekends and bank holidays.

show quoted sections